CSRIX | PHRCX | CSRIX / PHRCX | |
Total Expense Ratio | 0.75 | 1.99 | 38% |
Annual Report Gross Expense Ratio | 0.76 | 2.08 | 37% |
Fund Existence | 26 years | 22 years | - |
Gain YTD | 5.375 | 1.604 | 335% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.93B | 347M | 2,286% |
Annual Yield % from dividends | 3.01 | 1.14 | 264% |
Returns for 1 year | -3.57 | -9.89 | 36% |
Returns for 3 years | 12.99 | -13.47 | -96% |
Returns for 5 years | 40.08 | 4.74 | 846% |
Returns for 10 years | 51.20 | -44.95 | -114% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CVMAX | 21.37 | 0.04 | +0.19% |
Calvert Emerging Markets Equity A | |||
BRWTX | 28.64 | 0.04 | +0.14% |
MFS Blended Research Growth Eq R3 | |||
JWGRX | 130.48 | -0.31 | -0.24% |
Janus Henderson Global Research S | |||
VIMSX | 79.62 | -0.57 | -0.71% |
Vanguard Mid Cap Index Investor | |||
RSMRX | 15.79 | -0.24 | -1.50% |
RBC SMID Cap Growth R6 |